Clinical Trial Update: A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase I/II study evaluating romidepsin in combination with bortezomib for relapsed multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• Romidepsin (romidepsin)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN